OGSP yields 5.86% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, OGSP + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OGSP + PFE for your $10,000?
OGSP offers global exposure to investment grade securitized products through an active, opportunity-oriented approach. The fund invests across capital structures, maturity, and duration, based on the advisers assessment of market conditions. The portfolio may include asset-backed securities, collateralized debt, mortgage, and loan obligations, agency and non-agency mortgage-backed securities, and other instruments secured by financial, physical, or intangible assets. The portfolio will not focus on specific tranches or asset categories. The adviser uses a combination of fundamental, quantitative, and structural analysis to select holdings. The strategy focuses on evaluating each securitys opportunity for return compared to the potential risk. All portfolio assets are linked to interest or one or more derivatives, which may use leverage. To manage positions or pursue opportunities, the fund will be actively traded, especially during periods of market volatility.
Full OGSP Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.